Haizheng Biological Materials: 2024 net profit of 35.5046 million yuan, a year-on-year decrease of 18.47%.

GoldenOctober2024

Jin10 data reported on April 14th that Haizheng Biological Materials announced the release of its 2024 annual report, stating that the company achieved an operating income of 845 million yuan, a year-on-year rise of 12.20%; net profit was 35.5046 million yuan, a year-on-year decrease of 18.47%; the net profit after deducting non-recurring gains and losses was 31.2289 million yuan, a year-on-year decrease of 22.54%. The company intends to distribute a cash dividend of 0.6 yuan (tax included) for every 10 shares.

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.
Comment
0/400
No comments